TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 12/3030% below fair value
$1.82−0.03 (-1.62%)
Close on Nov 12, 2026Market cap $21.07MP/E –Yield –
TherapeuticsMD profit margin
Profit margin (net margin) is net income as a percentage of revenue.
TherapeuticsMD's profit margin for the twelve months ending Jun 30, 2026 was -6.6%. For fiscal 2025 it was -18.8%, against -123.9% the year before. The highest annual figure on record is 160.1% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -18.8% | +105.0 |
| FY2024 | Dec 31, 2024 | -123.9% | +665.6 |
| FY2023 | Dec 31, 2023 | -789.4% | −949.5 |
| FY2022 | Dec 31, 2022 | 160.1% | +6861.0 |
| FY2021 | Dec 31, 2021 | -6700.9% | −6418.0 |
| FY2020 | Dec 31, 2020 | -282.9% | +71.9 |
| FY2019 | Dec 31, 2019 | -354.8% | +468.9 |
| FY2018 | Dec 31, 2018 | -823.7% | −365.2 |
| FY2017 | Dec 31, 2017 | -458.5% | +5.8 |
| FY2016 | Dec 31, 2016 | -464.3% | −42.0 |
| FY2015 | Dec 31, 2015 | -422.4% | −61.5 |
| FY2014 | Dec 31, 2014 | -360.8% | −37.0 |
| FY2013 | Dec 31, 2013 | -323.8% | +596.0 |
| FY2012 | Dec 31, 2012 | -919.9% | −301.5 |
| FY2011 | Dec 31, 2011 | -618.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 17.8% | −40.0 |
| Q1 FY2026 | Mar 31, 2026 | 13.1% | +179.3 |
| Q4 FY2025 | Dec 31, 2025 | -69.3% | −107.1 |
| Q3 FY2025 | Sep 30, 2025 | 19.4% | +130.7 |
| Q2 FY2025 | Jun 30, 2025 | 57.9% | +523.7 |
| Q1 FY2025 | Mar 31, 2025 | -166.2% | +68.3 |
| Q4 FY2024 | Dec 31, 2024 | 37.8% | +213.7 |
| Q3 FY2024 | Sep 30, 2024 | -111.3% | +441.1 |
| Q2 FY2024 | Jun 30, 2024 | -465.8% | +400.3 |
| Q1 FY2024 | Mar 31, 2024 | -234.5% | −347.8 |
| Q4 FY2023 | Dec 31, 2023 | -175.9% | +8006.3 |
| Q2 FY2023 | Jun 30, 2023 | -552.4% | −32817.1 |
| Q1 FY2023 | Mar 31, 2023 | -866.1% | +6187.3 |
| Q4 FY2022 | Dec 31, 2022 | 113.3% | +343.3 |
| Q3 FY2022 | Sep 30, 2022 | -8182.2% | −7995.6 |
| Q2 FY2022 | Jun 30, 2022 | 32264.7% | +32450.1 |
| Q1 FY2022 | Mar 31, 2022 | -7053.4% | −6855.1 |
| Q4 FY2021 | Dec 31, 2021 | -230.0% | −43.6 |
| Q3 FY2021 | Sep 30, 2021 | -186.6% | −18.0 |
| Q2 FY2021 | Jun 30, 2021 | -185.4% | +300.3 |
| Q1 FY2021 | Mar 31, 2021 | -198.2% | +265.8 |
| Q4 FY2020 | Dec 31, 2020 | -186.4% | +124.5 |
| Q3 FY2020 | Sep 30, 2020 | -168.6% | −33.8 |
| Q2 FY2020 | Jun 30, 2020 | -485.7% | +422.9 |
| Q1 FY2020 | Mar 31, 2020 | -464.0% | +536.9 |
| Q4 FY2019 | Dec 31, 2019 | -310.9% | +463.2 |
| Q3 FY2019 | Sep 30, 2019 | -134.8% | +890.1 |
| Q2 FY2019 | Jun 30, 2019 | -908.7% | −25.9 |
| Q1 FY2019 | Mar 31, 2019 | -1000.9% | −354.2 |
| Q4 FY2018 | Dec 31, 2018 | -774.0% | −254.6 |
| Q3 FY2018 | Sep 30, 2018 | -1024.9% | −693.0 |
| Q2 FY2018 | Jun 30, 2018 | -882.8% | −419.8 |
| Q1 FY2018 | Mar 31, 2018 | -646.8% | −115.9 |
| Q4 FY2017 | Dec 31, 2017 | -519.4% | −10.5 |
| Q3 FY2017 | Sep 30, 2017 | -331.9% | +119.9 |
| Q2 FY2017 | Jun 30, 2017 | -463.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -530.9% | – |
| Q4 FY2016 | Dec 31, 2016 | -508.9% | – |
| Q3 FY2016 | Sep 30, 2016 | -451.9% | – |
See a number that looks wrong?